
Fifty 410 Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: pay-as-you-go compounded GLP-1 with no membership
Fifty 410 scores below our bar on medical oversight — read the score breakdown before signing up.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Fifty 410 is a no-membership, cash-pay telehealth service that connects you with licensed providers who can prescribe compounded semaglutide or tirzepatide from independent 503A compounding pharmacies. Month-to-month plans are $199/mo for either drug, with tirzepatide at all doses; 3-month tirzepatide programs run $133 to $183/mo, paid upfront. Provider review and free shipping are included, you pay only if prescribed, and FSA/HSA, Afterpay and Affirm are accepted.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Fifty 410
altRX
Best for: low-cost compounded GLP-1s with brand-name Zepbound, Wegovy and Ozempic as options
Editorial score · methodology
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Luvo Health
Best for: compounded and brand GLP-1s, oral tablets and microdosing on one public price list
Editorial score · methodology
Fifty 410 at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Compounded semaglutide, Compounded tirzepatide
- Starting price
- $199/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- 1 FDA warning letter on record — see below
How we scored Fifty 410
Each dimension is scored algorithmically from Fifty 410’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.0/10At $199/mo, Fifty 410 runs about 11% above the $179 median for GLP-1 providers (each one's cheapest ongoing monthly price). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.9/10Fifty 410 offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
5.8/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above); dispenses through an accredited compounding pharmacy.
Accessibility10%
6.3/10Fifty 410's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
5.7/10Fifty 410 provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Fifty 410 review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199/mo across 2 dose/plan tiers — checked October 2026
- State pharmacy licensing & LegitScript status
- LegitScript Certified
- FDA warning-letter register
- An active letter is on file for this provider — see below
What to expect when you sign up with Fifty 410
We walked Fifty 410’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Prices for every semaglutide and tirzepatide plan are listed on the public pricing pages.
- 2Click 'Get Started' or 'Start Your Journey' on the homepage.
- 3The intake opens on a third-party IntakeQ form whose first screen asks for your name and email or phone number (stopped here).
- Full price list is public before intake: $199/mo month-to-month for either drug, 3-month tirzepatide from $133/mo.
- 'No credit card required. Payment is requested only if a provider issues a prescription.'
- The intake form is hosted on IntakeQ and shows a different contact address (hello@clubcompound.com) at the top.
- Refund policy is clear: full refund before compounding begins, no routine refund after.
- Support is by email only; no phone number or hours are listed.
Fifty 410 customer support
- Help@fifty410.com
GLP-1 medications Fifty 410 offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$199 per 1-month supply, pay as you go. Provider review and free shipping included. No longer-plan discount listed for semaglutide.
$199 per 1-month supply, all doses. Longer plans: 3-mo starter $133/mo ($399), mid dose $166/mo ($499), high dose $183/mo ($549), paid upfront.
Ready to get started?
Plans and promotions change often — check Fifty 410's current pricing and active discounts before you decide.
What we like
- Clear public price list: $199/mo month-to-month for semaglutide or tirzepatide
- No membership or subscription; you buy each supply only when you need it
- No credit card to start, and you pay only if a provider prescribes
- 3-month tirzepatide programs drop the cost to as low as $133/mo
- Provider review and free 1-2 day refrigerated shipping included in the price
- Accepts FSA/HSA plus Afterpay and Affirm
Watch-outs
- Semaglutide price rose to $199/mo, with no multi-month discount listed
- The cheapest tirzepatide rates require paying for 3 months upfront
- No refunds once the pharmacy starts compounding your order
- Received an FDA warning letter in February 2026 over its compounded GLP-1 marketing
- Does not bill insurance, and no brand-name GLP-1 options
- Served-states list and clinician names are not published
Fifty 410: a no-membership way to buy compounded GLP-1
Fifty 410 is a stripped-down, cash-pay weight-loss service built around one idea: you pay for the medication you need and nothing else. There is no membership, no subscription to remember to cancel, and no separate consultation charge at checkout. Compounded semaglutide and tirzepatide both cost $199 a month on a month-to-month basis. That sits a little above the category median of $179, so its appeal now is simplicity and an open price list rather than rock-bottom cost.
How we get the category median: $179 is the middle value of the cheapest ongoing monthly price (not a first-month promo) at each of the 515 GLP-1 providers we track.
How the pricing really works
The monthly rate is $199 for either drug, and it doesn't rise as you titrate. Semaglutide comes only as a one-month supply, and Fifty 410 lists no longer-plan discount for it. Tirzepatide adds three-month programs paid upfront, split into starter, mid-dose and high-dose tiers. The starter tier works out to $133 a month, the lowest rate on the price list. The provider review and free shipping are built into every quoted number, so the price you see is the price you pay.
Semaglutide's price roughly doubled this year, and the old three-month semaglutide bundle is gone. If you priced Fifty 410 a few months ago, re-check before you plan around the old number. The homepage 'starting at' banner now matches the pricing table.
What's included in the number
- The compounded medication itself
- A licensed provider's review of your intake, with no separate consult fee
- Free refrigerated shipping that's quoted as one to two days
- No membership, no recurring platform charge
The medications and who fills them
Fifty 410 offers compounded semaglutide and compounded tirzepatide only. There are no branded GLP-1 pens, no oral options and no other drug classes on the menu. Its terms describe the compounding under Section 503A, the pharmacy route used for patient-specific prescriptions. A licensed provider reviews your intake, and medication ships directly to you if you're cleared. You also aren't asked for a card to start; payment is requested only if a provider prescribes.
Be clear-eyed about what compounded means. These are not FDA-approved finished drugs the way Wegovy or Zepbound are. A pharmacy custom-prepares them, and the FDA doesn't review them as packaged products. That's true of every compounding-based service, not a Fifty 410 flaw, but it's the most important thing to understand before you buy.
What sets it apart
The real differentiator is transparent public pricing paired with a true pay-as-you-go structure. Plenty of competitors hide their rate behind a quiz or lock you into a membership. Fifty 410 posts its full price list openly and runs no first-month teaser that resets later. It also accepts FSA/HSA cards and offers Afterpay and Affirm, which softens the upfront cost even though it won't bill your insurance. The site carries a LegitScript certification seal as well.
Where it falls short
A few gaps keep this from being a top pick. The company doesn't publish the states it serves, so you can't confirm availability without starting intake. Clinician names and credentials aren't disclosed either. Refunds are narrow: you get your money back only before the pharmacy starts compounding, and there's no routine refund after that. Support is email only, with no phone line listed. And the cheapest tirzepatide rate requires paying for three months at once.
Who should choose it, who should skip it
- Choose it if: you want a clear compounded price with no subscription, and you're comfortable paying cash, by FSA/HSA card or with a buy-now-pay-later plan
- Choose it if: you're on tirzepatide and willing to prepay three months for the lower tiered rate
- Skip it if: you want brand-name Wegovy or Zepbound, need insurance billing, or want named clinicians and a published state list first
- Skip it if: you're shopping purely on semaglutide price, since cheaper month-to-month options exist
Trust and safety
Fifty 410 received an FDA warning letter in February 2026 over its compounded GLP-1 marketing. The regulatory notice below covers it. On the positive side, the site carries a LegitScript seal and its refund policy is written in plain terms. Its prices also match across the homepage and the pricing table. The remaining drawbacks are about disclosure, with no published state list and no named clinicians, so confirm availability and ask about the prescribing provider before you pay. You can see how we weigh these factors in our scoring methodology.
The bottom line
Fifty 410 sells compounded semaglutide and tirzepatide at an open, membership-free price with shipping and the provider review baked in. At $199 a month it's no longer among the cheapest options, though tirzepatide buyers willing to prepay three months still get a strong rate. It fits a buyer who wants compounded GLP-1 without a subscription and doesn't need branded drugs or insurance billing. Go in knowing the limits: compounded isn't FDA-approved, refunds stop once compounding starts, and the served-states list isn't public.
Shopping around? Eden ($198/month) and Belle Health ($199/month) are the nearest alternatives to Fifty 410 in our rankings.
The Bottom Line
Fifty 410 scores below our bar on medical oversight — read the score breakdown before signing up.
Ready to start with Fifty 410?
Starting at $199/month. See current pricing and start your free consultation.
Fifty 410 might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider RxSpan MD.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Fifty 410 received an FDA warning letter dated February 20, 2026
The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity — companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Fifty 410 review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Fifty 410's current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.